Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.01. | RAMSAY HEALTH CARE LIMITED: Notification regarding unquoted securities - RHC | 1 | ASX | ||
07.01. | RAMSAY HEALTH CARE LIMITED: Notification of cessation of securities - RHC | 1 | ASX | ||
17.12.24 | RAMSAY HEALTH CARE LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
17.12.24 | RAMSAY HEALTH CARE LIMITED: Notification regarding unquoted securities - RHC | 1 | ASX | ||
RAMSAY HEALTH CARE LIMITED ADR Aktie jetzt für 0€ handeln | |||||
17.12.24 | RAMSAY HEALTH CARE LIMITED: Notification regarding unquoted securities - RHC | 1 | ASX | ||
05.12.24 | RAMSAY HEALTH CARE LIMITED: Change in substantial holding | - | ASX | ||
03.12.24 | RAMSAY HEALTH CARE LIMITED: Initial Director's Interest Notice | - | ASX | ||
03.12.24 | RAMSAY HEALTH CARE LIMITED: Final Director's Interest Notice | - | ASX | ||
26.11.24 | RAMSAY HEALTH CARE LIMITED: Amended Constitution | - | ASX | ||
26.11.24 | RAMSAY HEALTH CARE LIMITED: 2024 AGM - Results of Meeting | 2 | ASX | ||
24.11.24 | RAMSAY HEALTH CARE LIMITED: 2024 AGM Chair and Managing Director Address & Presentation | 1 | ASX | ||
23.11.24 | Ramsay Health Care (OTCMKTS:RMYHY) Hits New 52-Week Low - Time to Sell? | 2 | MarketBeat | ||
18.11.24 | RAMSAY HEALTH CARE LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
14.11.24 | RAMSAY HEALTH CARE LIMITED: 2024 Impact Report | 3 | ASX | ||
12.11.24 | RAMSAY SANTE: Ramsay Generale de Sante: preparatory documents availability for the 2024 General Meeting | 3 | GlobeNewswire (USA) | ||
06.11.24 | RAMSAY HEALTH CARE LIMITED: Ramsay Sante 1QFY25 Earnings Update | - | ASX | ||
22.10.24 | RAMSAY HEALTH CARE LIMITED: Ramsay Australia Investor Presentation | - | ASX | ||
21.10.24 | RAMSAY HEALTH CARE LIMITED: Dividend/Distribution - RHCPA | 1 | ASX | ||
02.10.24 | RAMSAY HEALTH CARE LIMITED: Notification of cessation of securities - RHC | - | ASX | ||
26.09.24 | RAMSAY HEALTH CARE LIMITED: Notice of Annual General Meeting/Proxy Form | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 52,00 | +5,05 % | Neue 14,25% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VG2U1Q5/ WKN VG2U1Q) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
FRESENIUS | 36,420 | +1,42 % | Leichte Zugewinne bei der Fresenius SE & Co. KGaA-Aktie (36,58 €) | Das Wertpapier von Fresenius SE & Co. KGaA notiert heute fester. Der jüngste Kurs betrug 36,58 Euro. Die Fresenius+Co KgaA-Aktie verzeichnet gegenwärtig einen Wertanstieg von 2,75 Prozent. Sie hat sich... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,560 | +2,47 % | Fresenius Medical Care Aktie: Richtung stimmt! | Die Fresenius Medical Care-Aktie setzt ihren positiven Trend fort und verzeichnet am 19. Januar 2025 einen Kursanstieg von 0,04 Prozent auf 44,88 EUR. Die Entwicklung der vergangenen Wochen zeigt eine... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 68,42 | 0,00 % | PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 2.8% - Should You Sell? | ||
BRIGHTSPRING HEALTH SERVICES | 21,210 | 0,00 % | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
NANO-X IMAGING | 8,980 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 54,00 | +0,07 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 53 Euro auf "Neutral" belassen. Im europäischen Medizintechnik-Bereich gebe... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 22,680 | -0,18 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2024 Financial Results | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared... ► Artikel lesen | |
BIOTEST | 27,000 | +0,37 % | Aktien KW 2 - US-Jobmarkt verdirbt die Party? Woche mit Paukenschlag. News. Auto1. Mutares. Nvidia. Kion. Magirus. Fuchs. INDUS. Biotest. Circus | Aktien Wochenrückblick - nach zwei ruhigen feiertagsgeprägten Wochen sah es diese Woche wieder so aus, als ob der DAX wieder auf Rekordkurs gehen wollte. Angebrannt ist nichts, aber die US-Jobdaten... ► Artikel lesen | |
GENEDX | 75,69 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
ATRICURE | 39,490 | 0,00 % | Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings) | ||
PROGYNY | 21,155 | 0,00 % | Witness A Substantial Acquisition As DEBRA MORRIS Acquires Progyny Stock Options Worth $37K | ||
ALIGNMENT HEALTHCARE | 14,610 | 0,00 % | Alignment Healthcare is latest to sue Medicare over Star Ratings | ||
GERRESHEIMER | 65,25 | -0,68 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
RXSIGHT | 31,930 | 0,00 % | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance | ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |